Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5866 posts found.

FDA approve first nonstimulant ADHD med for adults in two decades

May 3, 2022 Manufacturing and Production

The FDA has expanded the indication of Supernus’s Qelbree to patients aged 18 and older, marking the drug as the …
News

EC approves Cabotemyx as second-line treatment for thyroid cancer patients

May 3, 2022 Manufacturing and Production

The EC has approved the use of Cabotemyx (cabozantinib) as a monotherapy for the treatment of adult patients with locally …
News

UK study finds raising frequency of COPD flare ups increases risk of death

April 26, 2022 Manufacturing and Production

The EXACOS UK study in Chronic Obstructive Pulmonary Disease (COPD), funded by AstraZeneca, has shown that an increasing frequency of …
News

FDA approves first COVID-19 treatment for young children

April 26, 2022 Manufacturing and Production

The FDA has expanded the approval of the COVID-19 treatment, Veklury (remdesivir), to include pediatric patients 28 days of age …
News

AstraZeneca drug granted FDA Priority Review

April 19, 2022 Manufacturing and Production

AstraZeneca and Daiichi Sankyo have announced that the lung cancer antibody drug conjugate, Enhertu, has received Priority Review from the …
News

FDA accept New Drug Application for GSK’s daprodustat

April 19, 2022 Manufacturing and Production

GSK has announced the FDA has accepted the New Drug Application (NDA) for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase …
News

Tjaopack announces completion of Netherlands facility expansion

April 12, 2022 Manufacturing and Production

Tjaopack has announced the completion of its expansion plans, following a €10 million plus investment, at its Etten-Leur facility in …
News

Amid growing fears of antimicrobial-resistance, NHS payment scheme aims for pharma to tackle superbugs

April 12, 2022 Manufacturing and Production

NICE has shared that cefiderocol, and ceftazidime/avibactam, have the potential to save lives. The two medications, which fight drug-resistant superbugs, …
News

VR solution for personalised treatment and surgery guidance to spine surgeons

April 12, 2022 Manufacturing and Production

Seymourpowell and Axis Spine Technologies have announced a virtual reality (VR) solution allowing surgeons to evaluate and develop spinal implants …
News
shutterstock_187433765_16

European Commission approves treatment of unresectable uveal melanoma

April 5, 2022 Manufacturing and Production

Immunocore Holdings has announced that the European Commission has approved KIMMTRAK® (tebentafusp) for the treatment of HLA-A*02:01-positive adult patients with …
News

Technology enabling thermally-controlled DNA synthesis

April 5, 2022 Manufacturing and Production

Evonetix has been granted a patent in Europe for thermal control technology for DNA synthesis, as well as the design …
News

NHS struggling to make progress on early cancer diagnosis

April 5, 2022 Manufacturing and Production

MPs have warned that the NHS in England is struggling to make progress on its flagship target to diagnose three-quarters …
News

FDA approves generic version of brain imaging agent in US

April 5, 2022 Manufacturing and Production

The FDA has approved the generic version of DaTscan (Ioflupane I 123), manufactured and commercialised by Curium. This is a …
News
leipzig_skyline

FlyPharma Conference Europe: New dates and location announced

April 4, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.
News

CHMP recommends approval of Janssen’s first CAR-T therapy

March 29, 2022 Manufacturing and Production

Johnson & Johnson have announced the CHMP recommendation of marketing authorisation of ciltacabtagene autoleucel (cilta-cel) for the treatment of adults …
News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026